Hikma Pharmaceuticals (LON:HIK) Share Price Passes Above 200-Day Moving Average – Should You Sell?

Hikma Pharmaceuticals PLC (LON:HIK) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 2,014.14 ($26.79) and traded as high as GBX 2,040 ($27.14). Hikma Pharmaceuticals shares last traded at GBX 2,004 ($26.66), with a volume of 244,540 shares trading hands.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Berenberg Bank reissued a “buy” rating and set a GBX 2,560 ($34.06) target price on shares of Hikma Pharmaceuticals in a research note on Monday, March 10th. JPMorgan Chase & Co. reissued an “overweight” rating on shares of Hikma Pharmaceuticals in a research report on Friday, March 7th.

Hikma Pharmaceuticals Stock Down 1.0 %

The firm has a market cap of £5.56 billion, a PE ratio of 19.66, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41. The company has a quick ratio of 1.27, a current ratio of 1.66 and a debt-to-equity ratio of 55.82. The business has a 50-day moving average price of GBX 1,964.11 and a two-hundred day moving average price of GBX 2,014.14.

Hikma Pharmaceuticals Increases Dividend

The business also recently declared a dividend, which was paid on Thursday, May 1st. Shareholders of record on Thursday, March 20th were issued a dividend of $0.48 per share. This is an increase from Hikma Pharmaceuticals’s previous dividend of $0.32. The ex-dividend date of this dividend was Thursday, March 20th. This represents a yield of 1.8%. Hikma Pharmaceuticals’s dividend payout ratio is 60.84%.

Insider Activity

In other news, insider Victoria Hull sold 2,777 shares of the firm’s stock in a transaction on Tuesday, April 8th. The shares were sold at an average price of GBX 1,800 ($23.95), for a total value of £49,986 ($66,497.27). Company insiders own 30.54% of the company’s stock.

About Hikma Pharmaceuticals

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.